Quality of life at 2-year follow-up of SUPREMO randomised trial of post mastectomy radiotherapy for breast cancer Short title Quality of life after post mastectomy radiotherapy

eprints@whiterose.ac.uk https://eprints.whiterose.ac.uk/ Reuse This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) licence. This licence only allows you to download this work and share it with others as long as you credit the authors, but you can’t change the article in any way or use it commercially. More information and the full terms of the licence here: https://creativecommons.org/licenses/

[1]  T. Whelan,et al.  Ten years results of the Canadian breast intensity modulated radiation therapy (IMRT) randomized controlled trial. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  E. Wilkins,et al.  Effect of Patient Age on Outcomes in Breast Reconstruction: Results from a Multicenter Prospective Study. , 2016, Journal of the American College of Surgeons.

[3]  S. Edge,et al.  Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. , 2016, Practical radiation oncology.

[4]  S. Edge,et al.  Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update , 2016, Annals of Surgical Oncology.

[5]  B. Fosh,et al.  Quality of life following total mastectomy with and without reconstruction versus breast-conserving surgery for breast cancer: A case-controlled cohort study. , 2016, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[6]  L. V. van't Veer,et al.  70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer. , 2016, The New England journal of medicine.

[7]  G. Tienhoven,et al.  Determining the indications for post mastectomy radiotherapy: moving from 20th century clinical staging to 21st century biological criteria. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  D. Cameron,et al.  Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. , 2015, The Lancet. Oncology.

[9]  EBCTCG (Early Breast Cancer Trialists' Collaborati.  Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials , 2014, The Lancet.

[10]  S. Duffy,et al.  Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer , 2013, Breast Cancer Research.

[11]  P. Goodwin,et al.  Quality of life in long-term breast cancer survivors. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  H. Brenner,et al.  Quality of life in long-term breast cancer survivors – a 10-year longitudinal population-based study , 2013, Acta oncologica.

[13]  L. McLeod,et al.  Interpreting patient-reported outcome results: US FDA guidance and emerging methods , 2011, Expert review of pharmacoeconomics & outcomes research.

[14]  P. Ganz,et al.  Physical and psychosocial recovery in the year after primary treatment of breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. van der Pol,et al.  A randomised controlled trial of post-operative radiotherapy following breast-conserving surgery in a minimum-risk population. Quality of life at 5 years in the PRIME trial. , 2011, Health technology assessment.

[16]  B Rachet,et al.  Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data , 2011, Lancet.

[17]  J. Yarnold,et al.  Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials. , 2010, The Lancet. Oncology.

[18]  H. Kehlet,et al.  Prevalence of and factors associated with persistent pain following breast cancer surgery. , 2009, JAMA.

[19]  P. Cordeiro,et al.  Development of a New Patient-Reported Outcome Measure for Breast Surgery: The BREAST-Q , 2009, Plastic and reconstructive surgery.

[20]  G. Tienhoven,et al.  Elucidating the role of chest wall irradiation in 'intermediate-risk' breast cancer: the MRC/EORTC SUPREMO trial. , 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

[21]  J. Haviland,et al.  The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial). , 2007, Breast.

[22]  D. Buist,et al.  Quality of life of 5–10 year breast cancer survivors diagnosed between age 40 and 49 , 2004, Health and Quality of Life Outcomes.

[23]  G. Norman,et al.  Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation , 2003, Medical care.

[24]  T. Whelan,et al.  The effects of radiation therapy on quality of life of women with breast carcinoma: results of a randomized trial. Ontario Clinical Oncology Group. , 2000 .

[25]  C. Shapiro,et al.  Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  P. Dolan,et al.  Modeling valuations for EuroQol health states. , 1997, Medical care.

[27]  N. Aaronson,et al.  The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[29]  P. Fayers,et al.  Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  Penny Hopwood,et al.  A body image scale for use with cancer patients. , 2001, European journal of cancer.

[31]  G. Huston.  The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.